Piramal Pharma Limited
NSE: PPLPHARMA · Healthcare
₹207.71
-3.44 (-1.63%)
Last close · 30 Aug 2026, 11:54 am IST
- Open
- ₹211.60
- Day high
- ₹211.98
- Day low
- ₹206.40
- Volume
- 17.17 L
- Prev close
- ₹211.15
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 100Nifty Smallcap 250Nifty Smallcap 50
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 24,052 Cr
- Price
- 181.27
- P/E (TTM)
- -73.39
- P/E (Fwd)
- 43.00
- P/B
- 2.95
- EV/EBITDA
- 34.01
- EV/Revenue
- 3.20
- PEG
- —
- Div Yield
- 0.08%
- 52W High
- 210.50
- 52W Low
- 132.30
- Beta
- 0.39
Profitability & income
- Revenue (TTM)
- 8,869 Cr
- Net Income (TTM)
- -326 Cr
- EBITDA
- 835 Cr
- Gross Margin
- 59.66%
- Op. Margin
- 8.99%
- Net Margin
- -3.67%
- ROE
- -4.00%
- ROA
- 0.36%
- EPS (TTM)
- -2.47
- EPS (Fwd)
- 4.22
Financial health
- Total Debt
- 5,712 Cr
- Total Cash
- 1,355 Cr
- Debt/Equity
- 69.98
- Current Ratio
- 1.51
- Quick Ratio
- 0.76
- Book Value
- 61.50
- Free Cash Flow
- 680 Cr
- Op. Cash Flow
- 1,653 Cr
Growth
- Revenue Growth
- -0.10%
- Earnings Growth
- —
- Earnings QoQ
- —
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,752 Cr | -9 Cr | 344 Cr | 242 Cr | 1,696 Cr | — | 5,675 Cr | 8,163 Cr |
| 2025-12-31 | 2,140 Cr | -136 Cr | 208 Cr | -17 Cr | 1,354 Cr | — | — | — |
| 2025-09-30 | — | — | — | — | — | — | — | — |
| 2025-06-30 | 1,934 Cr | -82 Cr | 204 Cr | -91 Cr | 1,240 Cr | — | — | — |
| 2025-03-31 | 2,754 Cr | 154 Cr | 619 Cr | 318 Cr | 1,799 Cr | — | 4,856 Cr | 8,125 Cr |
| 2024-12-31 | 2,204 Cr | 4 Cr | 367 Cr | 141 Cr | 1,398 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 8,759 Cr | -326 Cr | 994 Cr | 155 Cr | 5,175 Cr | 1,653 Cr | 5,675 Cr | 8,163 Cr |
| 2025-03-31 | 9,061 Cr | 91 Cr | 1,649 Cr | 679 Cr | 5,489 Cr | 892 Cr | 4,856 Cr | 8,125 Cr |
| 2024-03-31 | 8,106 Cr | 18 Cr | 1,367 Cr | 462 Cr | 4,848 Cr | 1,005 Cr | 4,710 Cr | 7,911 Cr |
| 2023-03-31 | 7,032 Cr | -186 Cr | 894 Cr | -48 Cr | 4,032 Cr | 484 Cr | 5,637 Cr | 6,774 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for PPLPHARMA?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in